{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:26:52Z","timestamp":1780637212744,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11934-019-0865-9","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T05:29:40Z","timestamp":1547702980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Renal Medullary Carcinoma: a Report of the Current Literature"],"prefix":"10.1007","volume":"20","author":[{"given":"Leandro","family":"Blas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgelina","family":"Petroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Reniero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cicora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"3","key":"865_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.15586\/jkcvhl.2015.29","volume":"2","author":"JS Lee","year":"2015","unstructured":"Lee JS, Sanchez TR, Wootton-Gorges S. Malignant renal tumors in children. J Kidney Cancer VHL. 2015;2(3):84\u20139. \n                      https:\/\/doi.org\/10.15586\/jkcvhl.2015.29\n                      \n                    .","journal-title":"J Kidney Cancer VHL"},{"issue":"6","key":"865_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/bju.13705","volume":"120","author":"AY Shah","year":"2017","unstructured":"\u2022\u2022 Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, et al. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int. 2017;120(6):782\u201392. \n                      https:\/\/doi.org\/10.1111\/bju.13705\n                      \n                     Large and Current Case Series of RMC.","journal-title":"BJU Int"},{"issue":"1","key":"865_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","volume":"19","author":"C Davis","year":"1995","unstructured":"\u2022 Davis C, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19(1):1\u201311 First report of the condition.","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"865_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/pbc.25592","volume":"62","author":"O Alvarez","year":"2015","unstructured":"Alvarez O, Rodriguez MM, Jordan L, Sarnaik S. Renal medullary carcinoma and sickle cell trait: a systematic review. Pediatr Blood Cancer. 2015;62(10):1694\u20139. \n                      https:\/\/doi.org\/10.1002\/pbc.25592\n                      \n                    .","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"865_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.eururo.2005.11.035","volume":"49","author":"A Lopez-Beltran","year":"2006","unstructured":"Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49(5):798\u2013805. \n                      https:\/\/doi.org\/10.1016\/j.eururo.2005.11.035\n                      \n                    .","journal-title":"Eur Urol"},{"issue":"7","key":"865_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JOP.2017.020909","volume":"13","author":"KE Beckermann","year":"2017","unstructured":"Beckermann KE, Sharma D, Chaturvedi S, Msaouel P, Abboud MR, Allory Y, et al. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract. 2017;13(7):414\u201321. \n                      https:\/\/doi.org\/10.1200\/JOP.2017.020909\n                      \n                    .","journal-title":"J Oncol Pract"},{"key":"865_CR7","doi-asserted-by":"publisher","unstructured":"Di Stefano RF, Buttigliero C, De Luca E, Reale ML, Pisano C, Leone G, et al. Metastatic renal medullary carcinoma treated with immune checkpoint inhibitor: case report and literature review. Clin Genitourin Cancer. 2018. \n                      https:\/\/doi.org\/10.1016\/j.clgc.2018.07.011\n                      \n                    .","DOI":"10.1016\/j.clgc.2018.07.011"},{"issue":"9","key":"865_CR8","doi-asserted-by":"publisher","first-page":"e27267","DOI":"10.1002\/pbc.27267","volume":"65","author":"MA Carden","year":"2018","unstructured":"Carden MA, Perdahl-Wallace E, Greenberg J, McCarty JM. Autologous stem-cell transplant for metastatic renal medullary carcinoma. Pediatr Blood Cancer. 2018;65(9):e27267. \n                      https:\/\/doi.org\/10.1002\/pbc.27267\n                      \n                    .","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"865_CR9","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.21873\/anticanres.12657","volume":"38","author":"JZ Lai","year":"2018","unstructured":"Lai JZ, Lai HH, Cao D. Renal cell carcinoma, unclassified with medullary phenotype and synchronous renal clear cell carcinoma present in a patient with no sickle cell trait\/disease: diagnostic and therapeutic challenges. Anticancer Res. 2018;38(6):3757\u201361. \n                      https:\/\/doi.org\/10.21873\/anticanres.12657\n                      \n                    .","journal-title":"Anticancer Res"},{"issue":"1","key":"865_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13730-018-0308-3","volume":"7","author":"Y Goenaga-Vazquez","year":"2018","unstructured":"Goenaga-Vazquez Y, Colon G, Barrios N, Correa M. Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition. CEN Case Rep. 2018;7(1):121\u20136. \n                      https:\/\/doi.org\/10.1007\/s13730-018-0308-3\n                      \n                    .","journal-title":"CEN Case Rep"},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"2129450","DOI":"10.1155\/2017\/2129450","volume":"2017","author":"HR Ahmad","year":"2017","unstructured":"Ahmad HR, Faruk JA, Bugaje MA, Solomon A, Samaila MOA, Akuse RM. Sarcomatoid renal cell carcinoma in an adolescent with sickle cell anaemia. Case Rep Oncol Med. 2017;2017:2129450. \n                      https:\/\/doi.org\/10.1155\/2017\/2129450\n                      \n                    .","journal-title":"Case Rep Oncol Med"},{"issue":"7","key":"865_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1200\/jop.2017.023812","volume":"13","author":"DYC Heng","year":"2017","unstructured":"Heng DYC. Renal medullary carcinoma. J Oncol Pract. 2017;13(7):422\u20133. \n                      https:\/\/doi.org\/10.1200\/jop.2017.023812\n                      \n                    .","journal-title":"J Oncol Pract"},{"issue":"2","key":"865_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0974-7796.204184","volume":"9","author":"C Ibilibor","year":"2017","unstructured":"Ibilibor C, Medway A, Nelius T. Renal medullary carcinoma with an ophthalmic metastasis. Urol Ann. 2017;9(2):184\u20137. \n                      https:\/\/doi.org\/10.4103\/0974-7796.204184\n                      \n                    .","journal-title":"Urol Ann"},{"issue":"2","key":"865_CR14","first-page":"215","volume":"42","author":"S Caliskan","year":"2017","unstructured":"Caliskan S, Gokce AM, Gumrukcu G, Onenerk M. Renal medullary carcinoma; a rare entity. Iran J Med Sci. 2017;42(2):215\u20138.","journal-title":"Iran J Med Sci"},{"key":"865_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-016-0206-1","volume":"5","author":"KE Beckermann","year":"2017","unstructured":"Beckermann KE, Jolly PC, Kim JY, Bordeaux J, Puzanov I, Rathmell WK, et al. Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma. J Immunother Cancer. 2017;5:1. \n                      https:\/\/doi.org\/10.1186\/s40425-016-0206-1\n                      \n                    .","journal-title":"J Immunother Cancer"},{"issue":"1","key":"865_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000455007","volume":"10","author":"MR Kalavar","year":"2017","unstructured":"Kalavar MR, Ali S, Safarpour D, Kunnakkat SD. Renal medullary carcinoma with an aggressive clinical course: a case report and review of the literature. Case Rep Oncol. 2017;10(1):1\u20137. \n                      https:\/\/doi.org\/10.1159\/000455007\n                      \n                    .","journal-title":"Case Rep Oncol"},{"issue":"6","key":"865_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.eucr.2015.07.011","volume":"3","author":"P Colombo","year":"2015","unstructured":"Colombo P, Smith SC, Massa S, Renne SL, Brambilla S, Peschechera R, et al. Unclassified renal cell carcinoma with medullary phenotype versus renal medullary carcinoma: lessons from diagnosis in an Italian man found to harbor sickle cell trait. Urol Case Rep. 2015;3(6):215\u20138. \n                      https:\/\/doi.org\/10.1016\/j.eucr.2015.07.011\n                      \n                    .","journal-title":"Urol Case Rep"},{"issue":"4","key":"865_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/pbc.25832","volume":"63","author":"S Batra","year":"2016","unstructured":"Batra S. Is there a role for antiangiogenic therapy in renal medullary carcinoma? Pediatr Blood Cancer. 2016;63(4):746\u20137. \n                      https:\/\/doi.org\/10.1002\/pbc.25832\n                      \n                    .","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"865_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.JAA.0000464279.28870.3b","volume":"28","author":"MJ Rabener","year":"2015","unstructured":"Rabener MJ, Howell C. Chest discomfort in a patient with cancer. JAAPA: Official Journal of the American Academy of Physician Assistants. 2015;28(6):43\u20134, 466. \n                      https:\/\/doi.org\/10.1097\/01.JAA.0000464279.28870.3b\n                      \n                    .","journal-title":"JAAPA: Official Journal of the American Academy of Physician Assistants"},{"issue":"1","key":"865_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/15384047.2014.972843","volume":"16","author":"JS Lipkin","year":"2015","unstructured":"Lipkin JS, Rizvi SM, Gatalica Z, Sarwani NE, Holder SL, Kaag M, et al. Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression. Cancer Biol Ther. 2015;16(1):28\u201333. \n                      https:\/\/doi.org\/10.4161\/15384047.2014.972843\n                      \n                    .","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"865_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.rx.2014.09.003","volume":"57","author":"R Mast Vilaseca","year":"2015","unstructured":"Mast Vilaseca R, Pons EA. Renal medullary carcinoma in a young white adult without sickle cell trait or disease. Australas Radiol. 2015;57(4):361\u20133. \n                      https:\/\/doi.org\/10.1016\/j.rx.2014.09.003\n                      \n                    .","journal-title":"Australas Radiol"},{"issue":"2","key":"865_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5301\/uro.5000097","volume":"82","author":"GB Levi Sandri","year":"2015","unstructured":"Levi Sandri GB, Spoletini G, Lai Q, Mennini G, Rossi M. Cystic presentation of a renal medullary carcinoma in a young woman. Urologia. 2015;82(2):124\u20136. \n                      https:\/\/doi.org\/10.5301\/uro.5000097\n                      \n                    .","journal-title":"Urologia"},{"issue":"5","key":"865_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/cyt.12225","volume":"26","author":"K Tripathy","year":"2015","unstructured":"Tripathy K, Misra A, Dash K. Cytodiagnosis of renal medullary carcinoma: report of a case with immunocytochemistry. Cytopathology. 2015;26(5):328\u201330. \n                      https:\/\/doi.org\/10.1111\/cyt.12225\n                      \n                    .","journal-title":"Cytopathology"},{"key":"865_CR24","doi-asserted-by":"publisher","first-page":"615895","DOI":"10.1155\/2014\/615895","volume":"2014","author":"AI Amjad","year":"2014","unstructured":"Amjad AI, Ali H, Appleman LJ, Maranchie J, Jackman S, Parwani A, et al. Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Case Rep Oncol Med. 2014;2014:615895. \n                      https:\/\/doi.org\/10.1155\/2014\/615895\n                      \n                    .","journal-title":"Case Rep Oncol Med"},{"issue":"2","key":"865_CR25","first-page":"270","volume":"14","author":"A Shetty","year":"2014","unstructured":"Shetty A, Matrana MR. Renal medullary carcinoma: a case report and brief review of the literature. Ochsner J. 2014;14(2):270\u20135.","journal-title":"Ochsner J"},{"issue":"5","key":"865_CR26","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1097\/mph.0000000000000118","volume":"36","author":"P Daher","year":"2014","unstructured":"Daher P, Bourgi A, Riachy E, Khoury A, Rehayem C, Sader-Ghorra C. Renal medullary carcinoma in a white adolescent with sickle cell trait. J Pediatr Hematol Oncol. 2014;36(5):e285\u20139. \n                      https:\/\/doi.org\/10.1097\/mph.0000000000000118\n                      \n                    .","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"865_CR27","first-page":"893, 6, 8","volume":"27","author":"ET Lam","year":"2013","unstructured":"Lam ET, Kessler ER, Flaig TW, La Rosa FG. Collision renal cell papillary and medullary carcinoma in a 66-year-old man. Oncology (Williston Park, NY). 2013;27(9):893, 6, 8.","journal-title":"Oncology (Williston Park, NY)"},{"issue":"3","key":"865_CR28","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.4081\/rt.2013.e44","volume":"5","author":"MC Maroja Silvino","year":"2013","unstructured":"Maroja Silvino MC, Venchiarutti Moniz CM, Munhoz Piotto GH, Siqueira S, Galapo Kann A, Dzik C. Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil. Rare Tumors. 2013;5(3):e44. \n                      https:\/\/doi.org\/10.4081\/rt.2013.e44\n                      \n                    .","journal-title":"Rare Tumors"},{"issue":"3","key":"865_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/pbc.24795","volume":"61","author":"A Marsh","year":"2014","unstructured":"Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014;61(3):567. \n                      https:\/\/doi.org\/10.1002\/pbc.24795\n                      \n                    .","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"865_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4021\/wjon676w","volume":"4","author":"M Anne","year":"2013","unstructured":"Anne M, Sammartino D, Chaudhary S, Bhuiya T, Mehrotra B. Renal medullary carcinoma masquerading as bilateral breast carcinoma category: case report. World J Oncol. 2013;4(3):169\u201372. \n                      https:\/\/doi.org\/10.4021\/wjon676w\n                      \n                    .","journal-title":"World J Oncol"},{"issue":"1","key":"865_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40425-017-0267-9","volume":"5","author":"Q Sodji","year":"2017","unstructured":"Sodji Q, Klein K, Sravan K, Parikh J. Predictive role of PD-L1 expression in the response of renal medullary carcinoma to PD-1 inhibition. J Immunother Cancer. 2017;5(1):62. \n                      https:\/\/doi.org\/10.1186\/s40425-017-0267-9\n                      \n                    .","journal-title":"J Immunother Cancer"},{"issue":"1","key":"865_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jnma.2016.08.006","volume":"109","author":"SA Carter","year":"2017","unstructured":"Carter SA, Walker AN. Renal medullary carcinoma and sickle cell trait: a push for early diagnosis and intervention report of two cases. J Natl Med Assoc. 2017;109(1):63\u20135. \n                      https:\/\/doi.org\/10.1016\/j.jnma.2016.08.006\n                      \n                    .","journal-title":"J Natl Med Assoc"},{"key":"865_CR33","doi-asserted-by":"publisher","unstructured":"Carden MA, Smith S, Meany H, Yin H, Alazraki A, Rapkin LB. Platinum plus bortezomib for the treatment of pediatric renal medullary carcinoma: Two cases. Pediatr Blood Cancer. 2017;64(7). \n                      https:\/\/doi.org\/10.1002\/pbc.26402\n                      \n                    .","DOI":"10.1002\/pbc.26402"},{"issue":"3","key":"865_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/PAS.0b013e3182770406","volume":"37","author":"Q Liu","year":"2013","unstructured":"Liu Q, Galli S, Srinivasan R, Linehan WM, Tsokos M, Merino MJ. Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation. Am J Surg Pathol. 2013;37(3):368\u201374.","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"865_CR35","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1002\/cncr.29368","volume":"121","author":"JI Geller","year":"2015","unstructured":"Geller JI, Ehrlich PF, Cost NG, Khanna G, Mullen EA, Gratias EJ, et al. Characterization of adolescent and pediatric renal cell carcinoma: a report from the children's oncology group study AREN03B2. Cancer. 2015;121(14):2457\u201364. \n                      https:\/\/doi.org\/10.1002\/cncr.29368\n                      \n                    .","journal-title":"Cancer"},{"issue":"1","key":"865_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3892\/ol.2015.3891","volume":"11","author":"Z Shi","year":"2016","unstructured":"Shi Z, Zhuang Q, You R, Li Y, Li J, Cao D. Clinical and computed tomography imaging features of renal medullary carcinoma: a report of six cases. Oncol Lett. 2016;11(1):261\u20136. \n                      https:\/\/doi.org\/10.3892\/ol.2015.3891\n                      \n                    .","journal-title":"Oncol Lett"},{"issue":"12","key":"865_CR37","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00247-017-3926-6","volume":"47","author":"JK Sandberg","year":"2017","unstructured":"Sandberg JK, Mullen EA, Cajaiba MM, Smith EA, Servaes S, Perlman EJ, et al. Imaging of renal medullary carcinoma in children and young adults: a report from the children's oncology group. Pediatr Radiol. 2017;47(12):1615\u201321. \n                      https:\/\/doi.org\/10.1007\/s00247-017-3926-6\n                      \n                    .","journal-title":"Pediatr Radiol"},{"issue":"6","key":"865_CR38","doi-asserted-by":"publisher","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","volume":"15","author":"MI Carlo","year":"2017","unstructured":"Carlo MI, Chaim J, Patil S, Kemel Y, Schram AM, Woo K, et al. Genomic characterization of renal medullary carcinoma and treatment outcomes. Clin Genitourin Cancer. 2017;15(6):e987\u2013e94. \n                      https:\/\/doi.org\/10.1016\/j.clgc.2017.04.012\n                      \n                    .","journal-title":"Clin Genitourin Cancer"},{"key":"865_CR39","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Ezekian B, Englum B, Gilmore BF, Nag UP, Kim J, Leraas HJ et al. Renal medullary carcinoma: a national analysis of 159 patients. Pediatr Blood Cancer. 2017;64(11). \n                      https:\/\/doi.org\/10.1002\/pbc.26609\n                      \n                    . Large national analysis of RMC patients.","DOI":"10.1002\/pbc.26609"},{"issue":"3","key":"865_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/pas.0000000000001000","volume":"42","author":"C Ohe","year":"2018","unstructured":"Ohe C, Smith SC, Sirohi D, Divatia M, de Peralta-Venturina M, Paner GP, et al. Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol. 2018;42(3):279\u201392. \n                      https:\/\/doi.org\/10.1097\/pas.0000000000001000\n                      \n                    .","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"865_CR41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3949\/ccjm.82a.14029","volume":"82","author":"S Gebreselassie","year":"2015","unstructured":"Gebreselassie S, Simmons MN, Montague DK. Genitourinary manifestations of sickle cell disease. Cleve Clin J Med. 2015;82(10):679\u201383. \n                      https:\/\/doi.org\/10.3949\/ccjm.82a.14029\n                      \n                    .","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"865_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1093526617749671","volume":"21","author":"BR Pawel","year":"2018","unstructured":"Pawel BR. SMARCB1-deficient tumors of childhood: a practical guide. Pediatr Dev Pathol. 2018;21(1):6\u201328. \n                      https:\/\/doi.org\/10.1177\/1093526617749671\n                      \n                    .","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"865_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1053\/j.semdp.2016.08.005","volume":"33","author":"JA Jarzembowski","year":"2016","unstructured":"Jarzembowski JA. Pediatric renal and genitourinary tract tumors and the contributions of Dr. Louis \"Pepper\" Dehner therewith. Semin Diagn Pathol. 2016;33(6):419\u201326. \n                      https:\/\/doi.org\/10.1053\/j.semdp.2016.08.005\n                      \n                    .","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"865_CR44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","volume":"21","author":"A Agaimy","year":"2014","unstructured":"Agaimy A. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol. 2014;21(6):394\u2013410. \n                      https:\/\/doi.org\/10.1097\/PAP.0000000000000038\n                      \n                    .","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"865_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1053\/j.semdp.2015.02.004","volume":"32","author":"S Fleming","year":"2015","unstructured":"Fleming S. Distal nephron neoplasms. Semin Diagn Pathol. 2015;32(2):114\u201323. \n                      https:\/\/doi.org\/10.1053\/j.semdp.2015.02.004\n                      \n                    .","journal-title":"Semin Diagn Pathol"},{"issue":"5","key":"865_CR46","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1148\/rg.2017160189","volume":"37","author":"EM Chung","year":"2017","unstructured":"Chung EM, Lattin GE Jr, Fagen KE, Kim AM, Pavio MA, Fehringer AJ, et al. Renal tumors of childhood: radiologic-pathologic correlation part 2. The 2nd decade: from the radiologic pathology archives. Radiographics. 2017;37(5):1538\u201358. \n                      https:\/\/doi.org\/10.1148\/rg.2017160189\n                      \n                    .","journal-title":"Radiographics"},{"issue":"2","key":"865_CR47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4314\/ahs.v16i2.17","volume":"16","author":"M Anazoeze","year":"2016","unstructured":"Anazoeze M, Najibah G, Garba U, Shehu A, Florence F, Abdulaziz H, et al. Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey. Afr Health Sci. 2016;16(2):490\u20136. \n                      https:\/\/doi.org\/10.4314\/ahs.v16i2.17\n                      \n                    .","journal-title":"Afr Health Sci"},{"issue":"6","key":"865_CR48","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/jclinpath-2016-203650","volume":"69","author":"SN Kalimuthu","year":"2016","unstructured":"Kalimuthu SN, Chetty R. Gene of the month: SMARCB1. J Clin Pathol. 2016;69(6):484\u20139. \n                      https:\/\/doi.org\/10.1136\/jclinpath-2016-203650\n                      \n                    .","journal-title":"J Clin Pathol"},{"issue":"6","key":"865_CR49","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","volume":"69","author":"J Calderaro","year":"2016","unstructured":"\u2022 Calderaro J, Masliah-Planchon J, Richer W, Maillot L, Maille P, Mansuy L, et al. Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas. Eur Urol. 2016;69(6):1055\u201361. \n                      https:\/\/doi.org\/10.1016\/j.eururo.2015.09.027\n                      \n                     Paper on the explanatory model of genetic abnormalities in RMC.","journal-title":"Eur Urol"},{"issue":"9","key":"865_CR50","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1158\/1078-0432.Ccr-17-3296","volume":"24","author":"P Msaouel","year":"2018","unstructured":"\u2022 Msaouel P, Tannir NM, Walker CL. A model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma. Clin Cancer Res. 2018;24(9):2044\u20139. \n                      https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3296\n                      \n                     Proposed model on RMC.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"865_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/pas.0000000000000222","volume":"38","author":"MB Amin","year":"2014","unstructured":"Amin MB, Smith SC, Agaimy A, Argani P, Comp\u00e9rat EM, Delahunt B, et al. Collecting duct carcinoma versus renal medullary carcinoma. Am J Surg Pathol. 2014;38(7):871\u20134. \n                      https:\/\/doi.org\/10.1097\/pas.0000000000000222\n                      \n                    .","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"865_CR52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/PAP.0000000000000138","volume":"24","author":"AN Seo","year":"2017","unstructured":"Seo AN, Yoon G, Ro JY. Clinicopathologic and molecular pathology of collecting duct carcinoma and related renal cell carcinomas. Adv Anat Pathol. 2017;24(2):65\u201377. \n                      https:\/\/doi.org\/10.1097\/PAP.0000000000000138\n                      \n                    .","journal-title":"Adv Anat Pathol"},{"issue":"5","key":"865_CR53","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2214\/AJR.14.13514","volume":"204","author":"S Gupta","year":"2015","unstructured":"Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V. Diagnostic approach to hereditary renal cell carcinoma. AJR Am J Roentgenol. 2015;204(5):1031\u201341. \n                      https:\/\/doi.org\/10.2214\/AJR.14.13514\n                      \n                    .","journal-title":"AJR Am J Roentgenol"},{"issue":"3\u20134","key":"865_CR54","doi-asserted-by":"publisher","first-page":"E172","DOI":"10.5489\/cuaj.2373","volume":"9","author":"R Iacovelli","year":"2015","unstructured":"Iacovelli R, Modica D, Palazzo A, Trenta P, Piesco G, Cortesi E. Clinical outcome and prognostic factors in renal medullary carcinoma: A pooled analysis from 18 years of medical literature. Can Urol Assoc J. 2015;9(3\u20134):E172\u20137. \n                      https:\/\/doi.org\/10.5489\/cuaj.2373\n                      \n                    .","journal-title":"Can Urol Assoc J"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-019-0865-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-019-0865-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-019-0865-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:21:42Z","timestamp":1579220502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-019-0865-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1007\/s11934-019-0865-9","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"17 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Leandro Blas, Javier Roberti, Jorgelina Petroni, Liliana Reniero, and Federico Cicora each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"4"}}